Skip to main content
Log in

Simultaneous In Vivo Visualization and Localization of Solid Oral Dosage Forms in the Rat Gastrointestinal Tract by Magnetic Resonance Imaging (MRI)

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Bioavailability of orally administered drugs is much influenced by the behavior, performance and fate of the dosage form within the gastrointestinal (GI) tract. Therefore, MRI in vivo methods that allow for the simultaneous visualization of solid oral dosage forms and anatomical structures of the GI tract have been investigated.

Methods. Oral contrast agents containing Gd-DTPA were used to depict the lumen of the digestive organs. Solid oral dosage forms were visualized in a rat model by a 1H-MRI double contrast technique (magnetite-labelled microtablets) and a combination of 1H- and 19F-MRI (fluorine-labelled minicapsules).

Results. Simultaneous visualization of solid oral dosage forms and the GI environment in the rat was possible using MRI. Microtablets could reproducibly be monitored in the rat stomach and in the intestines using a 1H-MRI double contrast technique. Fluorine-labelled minicapsules were detectable in the rat stomach by a combination of 1H- and 19F-MRI in vivo.

Conclusions. The in vivo 1H-MRI double contrast technique described allows solid oral dosage forms in the rat GI tract to be depicted. Solid dosage forms can easily be labelled by incorporating trace amounts of non-toxic iron oxide (magnetite) particles. 1H-MRI is a promising tool for observing such pharmaceutical dosage forms in humans. Combined 1H- and 19F-MRI offer a means of unambiguously localizing solid oral dosage forms in more distal parts of the GI tract. Studies correlating MRI examinations with drug plasma levels could provide valuable information for the development of pharmaceutical dosage forms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. J. T. Fell and G. A. Digenis. Int. J. Pharm. 22:1–15 (1984).

    Google Scholar 

  2. I. R. Wilding, A. J. Coupe and S. S. Davis. Adv. Drug. Deliv. Rev. 7:87–117 (1991).

    Google Scholar 

  3. G. A. Digenis and E. Sandefer. Crit. Rev. Ther. Drug. Carrier Sys. 7:309–345 (1991).

    Google Scholar 

  4. S. S. Davis, J. G. Hardy, S. P. Newman and I. R. Wilding. Eur. J. Nucl. Med. 19:971–986 (1992).

    Google Scholar 

  5. K. P. Steed, G. Hooper, P. Ventura, R. Musa and I. R. Wilding. Int. J. Pharm. 112:199–206 (1994).

    Google Scholar 

  6. C. J. Kenyon, E. T Cole and I. R. Wilding. Int. J. Pharm. 112:207–213 (1994).

    Google Scholar 

  7. I. R. Wilding, S. S. Davis, M. Bakhshaee, H. N. E. Stevens, R. A. Sparrow and J. Brennan. Pharm. Res. 9(No. 5):654–657 (1992).

    Google Scholar 

  8. J. E. Devereux, J. M. Newton and M. B. Short. J. Pharm. Pharmacol. 42:500–501 (1990).

    Google Scholar 

  9. S. S. Davis, J. G. Hardy, M. J. Taylor, D. R. Whalley and C. G. Wilson. Int. J. Pharm. 21:331–340 (1984).

    Google Scholar 

  10. N. Follonier and E. Doelker. STP Pharma 2:141–158 (1992).

    Google Scholar 

  11. S. S. Davis, J. G. Hardy, M. J. Taylor, D. R. Whalley and C. G. Wilson. Int. J. Pharm. 21:167–177 (1984).

    Google Scholar 

  12. M. Sournac, J.-C. Maublant, J.-M. Aiache, A. Veyre and J. Bougaret. J. Contr. Rel. 7:139–146 (1988).

    Google Scholar 

  13. P. R. Ros and L. H. Ros Mendoza. In P. R. Ros and W. D. Bidgood (eds.), Abdominal magnetic resonance imaging, Mosby, St. Louis, 1993, pp. 165–171.

    Google Scholar 

  14. F. Schnitger. Enteral MRI contrast media—Progress in magnetic resonance imaging of abdomen and pelvis, Springer-Verlag, Berlin, 1994. Insert in European Radiology 4,No. 2 (1994).

    Google Scholar 

  15. S. M. Rocklage, A. D. Watson and M. J. Carvlin. In D. D. Stark and W. G. Bradley (eds.), Magnetic Resonance Imaging, Mosby Year Book, Second Edition 1992, Vol. 1, Chapter 14.

  16. J. R. Ballinger. In P. R. Ros and W. D. Bidgood (eds.), Abdominal magnetic resonance imaging, Mosby, St. Louis, 1993, pp. 116–133.

    Google Scholar 

  17. M. Laniado, W. Kornmesser, B. Hamm, W. Clauss, H.-J. Weinmann and R. Felix. AJR 150:817–821 (1988).

    Google Scholar 

  18. K. C. P. Li, P. G. P. Ang, R. P. Tart, B. L. Storm, R. Rolfes and P. C. K. Ho-Tai. Magn. Reson. Imag. 8:589–598 (1990).

    Google Scholar 

  19. H. Friebolin. Ein-und zweidimensionale NMR-Spektroskopie, VCH Verlagsgesellschaft mbH, Weinheim (Germany), 1992.

    Google Scholar 

  20. Aldrich Catalogue 1994–1995, Aldrich-Chemie GmbH & Co. KG, Steinheim (Germany), 1994, p. 841.

  21. Bruker Almanac 1995, Bruker Instruments Inc., Billerica (USA), 1995, p. 66.

  22. S. J. Anie, J. T. Fell, R. D. Waigh and B. Wood. Int. J. Pharm. 76:183–185 (1991).

    Google Scholar 

  23. R. M. Henkelman and M. J. Bronskill. In J. C. Gore (ed.), Reviews of Magnetic Resonance in Medicine, Vol. 2,No. 1, Pergamon Press, New York, 1987, pp. 40–51.

    Google Scholar 

  24. K. M. Lüdeke, P. Röschmann and R. Tischler. Magn. Reson. Imag. 3:329–343 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claus-Michael Lehr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christmann, V., Rosenberg, J., Seega, J. et al. Simultaneous In Vivo Visualization and Localization of Solid Oral Dosage Forms in the Rat Gastrointestinal Tract by Magnetic Resonance Imaging (MRI). Pharm Res 14, 1066–1072 (1997). https://doi.org/10.1023/A:1012161630481

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012161630481

Navigation